Recent Finacing
Recent Raise
Outpace Bio develops AI-guided protein design and synthetic biology platform to engineer programmed T cells, including mesothelin-specific OPB-101 CAR T, and to extend into broader cell and gene therapies.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Outpace Bio.
